Analysis - Page 1

Stay up to date with the latest Analysis updates from the global pharmaceutical industry

Latest Analysis Update

Less is more: why rare disease funding is on the up 02 February, 2012 Despite reductions in R&D spending, clinical trials for rare diseases are going full steam ahead. Elly Earls speaks to Alastair Kent of Genetic Alliance UK, Tim Cote of the National... > read more

Ahead in the cloud – a new home for clinical trial data 31 January, 2012 As the volume and complexity of clinical trial data grows, scientists need new ways to filter information. Elly Earls speaks to SAFE Bio-Pharma's Mollie Shields-Uehling and IBM's Chris Hines...

Taking aim with nanotechnology 16 November, 2011 One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor,...

API compliance – safeguarding the supply chain 15 September, 2011 In the war against fake medicines, protecting the upstream supply chain will be a decisive battle. Dr Gareth Evans reports on how the Council of the European Union's initial formal adoption of...

Calling on contract manufacturing 30 August, 2011 Outsourcing the pharmaceutical pipeline has become a popular option for companies big and small. Frances Cook talks to leading contract developer and manufacturer of pharmaceuticals Aesica...

Mighty materials: the challenges of developing potent APIs 25 August, 2011 What solutions are available for producing increasingly powerful active pharmaceutical ingredients? Sarah Blackman talks to Stuart Needleman of Aptuit about the manufacturing methods used to...

Snapshot: Prostate Cancer - Global Drug Forecasts and Treatment Analysis 01 August, 2011 Prostate cancer is the most common form of the disease in men but as yet, no one-size fits all treatment is available. Using detailed GlobalData research this market snapshot analyses the...

The Need for Speed: Imaging Biomarkers in Clinical Trials 27 July, 2011 Imaging biomarkers could hold the key to faster, more cost-effective drug development if used properly. Chris Lo speaks to Clinical Trials Network chairman Dr Michael Graham to find out more...

Snapshot: Coronary Artery Disease Global Clinical Trials 2011 13 May, 2011 An estimated 17 million people die of coronary artery disease worldwide every year, and numbers are rising. While pharmaceutical efforts to find a cure have always been fiercely competitive,...

Snapshot: Respiration Disorders Global Clinical Trials 06 May, 2011 Major trials are underway for treatments of respiration disorder, the second biggest cause of death worldwide. As pollution levels increase and disorders become more likely, the race to treat...

Snapshot: Global Pain Clinical Trials Q1 2011 27 April, 2011 The global pain market is a moderately growing market with huge potential for growth. A number of patent expiries in the near future could provide more twists in the tale, but are we any closer...

Features By Category view all